Govt review finds no common thread in post-delivery deaths
Jaipur: A clinical evaluation by the state govt of post-delivery fatalities and complications reported from govt hospitals in Kota, Bikaner and Jodhpur since last month has found no common pattern…
Gurgaon call centre busted for cheating people with fake weight-loss products, 3 women held
GURGAON: A fraudulent call centre allegedly duping people on the pretext of selling weight-loss medicines was busted in Udyog Vihar Phase-5, with three women arrested, police said on Sunday.The Cyber…
Madhya Pradesh toddler loses vision after doctor administers drops, probe underway
A 19-month-old child has lost his vision, with his family accusing a doctor at a civil hospital in Madhya Pradesh’s Sagar district of administering saline nasal drops into his eyes…
CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences
New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a critical regulatory directive aimed at completely digitizing and streamlining the import and registration protocols for biological products in India.…
WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled
The World Health Organisation (WHO) has sought details from the Indian government following reports linking oxytocin injection manufactured by Jackson Laboratories to maternal deaths case in Rajasthan, even as the Centre clarified…
DDA seizes suspected counterfeit asthma medicine in nationwide crackdown
Stocks were confiscated from wholesalers and retailers in Kathmandu Valley, Rupendehi and Kailali. In a major crackdown on illicit and counterfeit drugs being sold in Nepal under the name of…
HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses
In a landmark ruling that will have far-reaching implications for the pharmaceutical sector, the High Court of Himachal Pradesh has quashed three criminal complaints filed by the Central Drugs Standard…
Eli Lilly launches cancer drug Tanstrive in India
New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…
Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals
The Evidence is in Landmark Study published in the Journal of Medical Evidence New Delhi: Sir Ganga Ram Hospital excels in medical research among private hospitals as it is the…
Centre eases BIS quality compliance with new risk-based framework for manufacturers
The Centre has introduced a risk-based compliance mechanism to ease industry compliance with Quality Control Orders (QCOs), allowing eligible manufacturers to follow a simplified certification route while maintaining product quality…
%20to%20Vaccine%20and%20Anti-Sera%20Import%20Licences){kind=link}
